DE EN

3rd RESOLUTE Consortium Meeting 6-8 November 2019

3rd RESOLUTE Consortium Meeting 6-8 November 2019
RESOLUTE partners that participated at the 3rd RESOLUTE Consortium Meeting in Milan, Italy
On 6-8 November 2019, the 3rd RESOLUTE Consortium Meeting took place near Milan, Italy, and was hosted by Axxam within OpenZone. RESOLUTE is a public-private partnership, funded with a grant from the Innovative Medicines Initiative (IMI) and coordinated by CeMM and Pfizer, with 13 partners from academia and industry.

The first day of the meeting kicked off with updates from several RESOLUTE partners, which showcased the progress achieved since the last consortium meeting in Krems, Austria, in June 2019.

The second day was dedicated to a “Data Integration workshop”, where participants discussed insights and tools to extract knowledge from the combination of diverse data types generated within the RESOLUTE project. The workshop included keynote talks by Avner Schlessinger (Mount Sinai, New York, USA), Rob Russell and Francesco Raimondi (BioQuant Heidelberg, Germany), and Patrick Aloy (IRB, Barcelona, Spain). EFPIA representatives Andreas Steffen (Bayer AG), Robert Stanton (Pfizer Ltd), and Karsten Quast (Boehringer Ingelheim), as well as CeMM members Enrico Girardi and Eva Meixner, shared specific examples and tools related to data integration.

On the last day, RESOLUTE external collaborators presented several strategies to develop high-affinity binders for Solute Carriers (SLCs), which will help boost research on this protein class. This was followed by project-specific discussions leading to the definition of current priorities and plans for the upcoming year of RESOLUTE.

We would like to thank OpenZone and Axxam for the smooth organisation, and all participants and partner institutions for their enthusiasm and fruitful discussions!

Find out more about RESOLUTE: https://re-solute.eu

Artikel teilen